Compliance Rate
Compliance Rate
100.0%
Compliant submissions
2
Incompliant submissions
0
Total trials
2
My Organizations' Clinical Trials
Showing 725 of 910 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/27/16
End: 02/27/19
Due: 02/27/20
Phase: N/A
Priority: Normal
Start: 11/20/18
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 03/07/18
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 10/20/20
End: 05/01/24
Due: 05/01/25
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 03/23/22
End: 06/01/25
Due: 06/01/26
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 01/31/12
Due: 01/31/13
Triphalangeal Thumbs in the Pediatric Population: Long Term Outcomes Following Surgical Intervention
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 05/05/22
End: 01/10/23
Due: 01/10/24
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 03/22/21
End: 05/14/21
Due: 05/14/22
Phase: N/A
Priority: Normal
Start: 05/05/18
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 11/28/23
End: 11/30/27
Due: 11/30/28
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 06/22/20
Due: 06/22/21
Phase: N/A
Priority: Normal
Start: 01/27/20
End: 03/30/22
Due: 03/30/23
Phase: N/A
Priority: Normal
Start: 08/31/05
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 06/01/19
Due: 06/01/20
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 04/30/21
Due: 04/30/22